tuberculosis/fungal infections therapeutics (Central Drug Research Institute)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nametuberculosis/fungal infections therapeutics (Central Drug Research Institute)
Drug Alias Namegalactopyranose derivatives (CDRI)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycosyltransferases inhibitors
TargetsGlycosyltransferases
Therapy Area/IndicationsMycosesTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentral Drug Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentral Drug Research Institute
Active IndicationsN/A
Inactive IndicationsMycosesTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A